Fig. 2From: MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumorsBox-plots and ROC curves for miR-34b/c, miR-129-2, miR-152, miR-193b, miR-663a and miR-1258 promoter methylation levels in morphologically normal prostate tissue (MNPT) and malignant (PCa) prostatic tissues from Cohort #1Back to article page